Ruboxistaurin, a Protein Kinase C β Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications

TY - JOUR

T1 - Ruboxistaurin, a Protein Kinase C β Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications

AU - Joy, Scott V

AU - Scates, Ann C

AU - Bearelly, Srilaxmi

AU - Dar, Moahad

AU - Taulien, Christina A

AU - Goebel, Jason A

AU - Cooney, Michael J

N1 - To review current clinical data regarding the pharmacologic actions of ruboxistaurin (LY333531) mesylate, an inhibitor of protein kinase C (PKC) β, and its role to potentially reduce the development and/or the progression of diabetic microvascular complications. Primary literature was obtained via a MEDLINE search (1966-August 2004) and through review of pertinent abstracts and presentations at major medical meetings.

PY - 2005/10/1

Y1 - 2005/10/1

UR - https://journals.sagepub.com/doi/abs/10.1345/aph.1E572

U2 - 10.1345/APH.1E572

DO - 10.1345/APH.1E572

M3 - Article

VL - 39

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

IS - 10

ER -